In this interview, Nauman Shah, Global Head, Janssen Business Development, discusses the new era of collaboration and the outlook for pharma business development that will lead to future innovation.

On track to deliver Portfolio Receipts of $4.7 billion or more by 2030, significantly ahead of consensus Goal to achieve at least mid-teens ...

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Corium Pharma Solutions, Inc. (“Corium Pharma Solutions” or “CPSI”), a leading, full-service contract development and manufacturing organization specializing in ...

Amneal is a pharma brand with a diverse and growing drug portfolio, strong cash flow metrics, and an improving debt situation ...

Strides Pharma partners with Kenox Pharmaceuticals for nasal spray products, combining strengths for US market expansion.

LILLE, France--(BUSINESS WIRE)--4P-Pharma, a pioneering biotechnology company based in Lille and specializing in drug regeneration, is thrilled to achieve a significant milestone in its history.

Executives at Novartis have not been shy about a desire to buy more companies, with cardiovascular a big focus. In total, the ...

Orasi Medical Inc. said Danish drugmaker H. Lundbeck A/S will use its software to test experimental drug compounds on the human brain. Spun out of the University of Minnesota, Orasi has developed ...

Royalty Pharma (RPRX) will host an Investor Day in New York City. Senior executives will provide an update on the company’s plans to drive ...

The Bulk Drug Park in Una, Himachal Pradesh, has received environmental clearance, enabling its development to reduce ...

Fidson Healthcare Plc has announced a deepened strategic alliance with Japanese firm, Ohara Pharmaceutical Co., Limited. The ...

The latest contract was signed a few days ago, bringing the total to 20 pharmaceutical and para-pharmaceutical companies ...